Providing in-depth mesothelioma news coverage related to mesothelioma and asbestos-related lung cancers, including treatment breakthroughs, litigation trends, and exposure risks.
A federal judge will rule next week on what evidence will be admitted in ongoing lawsuits against Johnson & Johnson (J&J) alleging that asbestos in the company’s talc-based products has caused ovarian cancer and mesothelioma. The outcome of the hearing in a...
read more
Chemotherapy with Niraparib can extend the life of ovarian cancer patients who have already undergone 4 or more chemotherapy treatments. American researchers give hope to ovarian cancer patients who have undergone several rounds of chemotherapy treatment and have lost...
read more
New dimensions in radiotherapy are paving the way to strategize pleural mesothelioma treatment. Changes in the fractionation of radiation dosage, use of Stereotactic Body Radiation Therapy- SBRT as salvage therapy and combining radiotherapy with immunotherapy are few...
read more
Avelumab Treatment can restrict the tumor progression in mesothelioma patients who have previously received chemotherapy. This treatment is safe to use as second-line therapy for mesothelioma. Researchers from the National Cancer Institute, National Institute of...
read more
Chinese researchers observed that DFMO (a-difluoromethylornithine) treatment could significantly restrict the tumor growth in resectable malignant pleural mesothelioma (MPM) patients who have undergone U.S. FDA approved chemotherapeutic treatment. DFMO treatment...
read more
French researchers found that BDNF- Brain-derived neurotrophic factor is linked with the start and spread of the tumor in malignant pleural mesothelioma. Additional research can improve diagnosis and mesothelioma treatment.
read more
Researchers revealed that excessive genital use of talcum powder changes the enzymatic activity favoring ovarian cancer cells' survival. Moreover, with changes at the molecular level, it also causes a reduction in ovarian cancer cell death (apoptosis) and increases in...
read more
A jury in California ordered Johnson & Johnson to pay $29.4 million to a woman who believes her mesothelioma is tied to her regular use of Johnson & Johnson’s talcum powder.
read more
California resident Eva Echeverria claims that she developed ovarian cancer after using the company’s talc-based product for feminine hygiene. The verdict marks one of the most substantial sums in the series of talcum powder lawsuit verdicts against J&J. The Jury...
read more
Swiss researchers are developing a gel-based chemotherapeutic approach to treat malignant pleural mesothelioma. Initial results have suggested that delivering cancer-fighting drugs such as cisplatin bound with "natural glue" can be a toxicity free and efficient way to...
read more